.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
US Department of Justice
Argus Health
Fish and Richardson
Harvard Business School
Fuji
Covington
UBS
Express Scripts

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040349

« Back to Dashboard

NDA 040349 describes SULFASALAZINE, which is a drug marketed by Vintage Pharms, Watson Labs, Heritage Pharms Inc, Sandoz, Sun Pharm Industries, and Superpharm, and is included in ten NDAs. It is available from nine suppliers. Additional details are available on the SULFASALAZINE profile page.

The generic ingredient in SULFASALAZINE is sulfasalazine. There are ten drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.

Summary for 040349

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 040349

Ingredient-typeAminosalicylic Acids

Suppliers and Packaging for NDA: 040349

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULFASALAZINE sulfasalazine TABLET;ORAL 040349 ANDA Qualitest Pharmaceuticals 0603-5801 0603-5801-32 1000 TABLET in 1 BOTTLE, PLASTIC (0603-5801-32)
SULFASALAZINE sulfasalazine TABLET;ORAL 040349 ANDA Qualitest Pharmaceuticals 0603-5801 0603-5801-04 180 TABLET in 1 BOTTLE, PLASTIC (0603-5801-04)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Jan 11, 2002TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Fuji
Citi
Boehringer Ingelheim
McKesson
Accenture
Daiichi Sankyo
Harvard Business School
McKinsey
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot